El Hospital del Mar, es un centro sanitario general moderno, universitario, activo, investigador, que atiende patologías de complejidad media y alta situado en el Paseo Marítimo de Barcelona. Fue inaugurado en el año 1905, siendo uno de los hospitales más importantes de Barcelona.

During the past decade, Hospital del Mar; Servicio de Oncologia conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 17 clinical trials were completed, i.e. on average, 54.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital del Mar; Servicio de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 37 trials, followed by "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital del Mar; Servicio de Oncologia" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital del Mar; Servicio de Oncologia" are "Breast Cancer" (9 trials), "Non-small Cell Lung Cancer" (4 trials), "Solid Tumors" (4 trials), "Neoplasms" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Hospital del Mar; Servicio de Oncologia" in a lesser frequency.

Most popular intervention types in "Hospital del Mar; Servicio de Oncologia" are "Drug" (44 trials), "Radiation" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (10 trials), "Placebo" (9 trials), "Pertuzumab" (8 trials), "Trastuzumab" (8 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital del Mar; Servicio de Oncologia" are 43 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital del Mar; Servicio de Oncologia". undefined are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Hospital del Mar; Servicio de Oncologia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital del Mar; Servicio de Oncologia, 13 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".